Shandong Xinhua Pharmaceutical Company Limited announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 4,638.516 million compared to CNY 4,430.700 million a year ago. Operating income was CNY 335.629 million compared to CNY 320.204 million a year ago. Net income was CNY 246.066 million compared to CNY 241.161 million a year ago. Basic earnings per share from continuing operations was CNY 0.4 compared to CNY 0.39 a year ago.